|
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
|
2R01CA173481-06
|
$385,883
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Nanoparticle mediated microenvironmental targeting of CCL3 signaling for the treatment of acute myelogenous leukemia
|
1F31CA228391-01
|
$42,418
|
|
ACKUN-FARMMER, MARIAN
|
UNIVERSITY OF ROCHESTER
|
|
Genetics of Graft-versus-Host Disease
|
1R01CA231141-01
|
$265,229
|
|
AFSHAR-KHARGHAN, VAHID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer
|
5K08CA218420-02
|
$177,120
|
|
AGUIRRE, ANDREW
|
DANA-FARBER CANCER INST
|
|
Mutagenesis and migration in glioblastoma cells
|
1R21CA220111-01A1
|
$179,240
|
|
AHN, EUN HYUN
|
UNIVERSITY OF WASHINGTON
|
|
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
|
5F30CA220847-02
|
$49,524
|
|
ALI, MOIEZ
|
DUKE UNIVERSITY
|
|
Profiling signaling activity and gene expression in single, pancreatic adenocarcinoma cells using CE-RNA-Seq
|
1R01CA224763-01A1
|
$575,272
|
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
|
5P01CA196539-04
|
$1,855,117
|
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy
|
5R01CA184137-04
|
$362,569
|
|
ALMASAN, ALEXANDRU
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
|
5U01CA202144-04
|
$741,952
|
|
ALTER, ORLY
|
UNIVERSITY OF UTAH
|
|
Novel Molecular Therapies of Prostate Cancer
|
5P01CA140043-09
|
$1,222,825
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Tumor Plasticity
|
5R35CA220446-02
|
$1,140,000
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
High Resolution Microendoscopy for the Management of Esophageal Neoplasia
|
5R01CA181275-05
|
$307,736
|
|
ANANDASABAPATHY, SHARMILA
|
BAYLOR COLLEGE OF MEDICINE
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-04
|
$701,778
|
$14,036
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The regulation of dendritic cell function by LMYC at steady state and during immune responses to cancer
|
1F31CA228240-01
|
$30,442
|
|
ANDERSON, DAVID
|
WASHINGTON UNIVERSITY
|
|
Performance, safety, and efficacy of a new cyrotherapy device for cervical dyspla
|
5UH3CA189923-05
|
$762,683
|
|
ANDERSON, JEAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Defining the Transcriptional Regulation and Genomic Organization of FAIM3 and PIGR, Human Ig Receptors Involved in Immunity, Auto-Immune Disease, and Lymphoma
|
5F31CA221012-02
|
$30,434
|
|
ANDREWS, JARED
|
WASHINGTON UNIVERSITY
|
|
Cancer Metabolism Training Program
|
1T32CA221709-01A1
|
$201,444
|
|
ANN, DAVID
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Clinical Validation of the Multiple Biopsy Device, a Novel Endoscopic Biopsy Technology
|
1R43CA228656-01
|
$206,274
|
|
APPLING, ANTHONY
|
ENDOSCOPIC ASSIST DEVICES, LLC
|
|
Research Training in Pediatric Oncology
|
5T32CA136432-10
|
$491,462
|
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132384-09
|
$1,192,031
|
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
Reversing Cellular immortality in cancer
|
5R35CA197563-04
|
$962,915
|
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-08S1
|
$175,000
|
$3,500
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-08
|
$2,480,000
|
$49,600
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Dual Targeting Redox?active Gold(I) Therapeutics
|
1R15CA232765-01
|
$462,195
|
|
ARUMUGAM, KUPPUSWAMY
|
WRIGHT STATE UNIVERSITY
|
|
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
|
1R01CA230516-01
|
$564,655
|
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
$67,654
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SA
|
$124,999
|
$1,250
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SB
|
$59,999
|
$600
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis
|
1R01CA222358-01A1
|
$635,306
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Nutritionally Driven Sporadic Intestinal Tumors: Impact on Stem Cells
|
1R01CA229216-01
|
$493,238
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Novel ODC Inhibitor Phaseolotoxin in Neuroblastoma
|
1R21CA216867-01A1
|
$193,750
|
|
BACHMANN, ANDRE
|
MICHIGAN STATE UNIVERSITY
|
|
Translating buccal nanocytology for lung cancer screening into clinical practice
|
1R01CA225002-01A1
|
$638,469
|
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
EXPLORER: Changing the Molecular Imaging Paradigm with Total Body PET
|
5R01CA206187-04
|
$1,000,000
|
|
BADAWI, RAMSEY
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Macrophage-Microbiota Interactions in Colon Cancer
|
1F31CA225044-01A1
|
$35,917
|
|
BADER, JACKIE
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases
|
5U01CA217846-02
|
$974,850
|
|
BADER, JOEL
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQC3) Ethnicity-determined immune response and DCIS outcome
|
5R01CA194600-04
|
$179,518
|
|
BADVE, SUNIL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Puerto Rico NCI Community Oncology Research Program Minority/Underserved
|
5UG1CA189862-05
|
$717,072
|
|
BAEZ- DIAZ, LUIS
|
COMPREHENSIVE CANCER CENTER/ UNIV/PR
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-05
|
$826,500
|
|
BAILEY, LISA
|
BAY AREA TUMOR INSTITUTE
|
|
2/2 The GUIDE Cancer Research Training Project
|
5P20CA202907-04
|
$204,897
|
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
MammoCAT Advanced Full Field Digital Mammography System
|
1R43CA224851-01A1
|
$299,950
|
|
BAMBOT, SHABBIR
|
FISCHER IMAGING, INC.
|
|
Oncogenic Ras-induced macropinocytosis: A new paradigm for metabolic adaptation
|
5R35CA210263-03
|
$968,501
|
|
BAR-SAGI, DAFNA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-04
|
$334,911
|
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
A-to-I microRNA Editing and Melanoma Metastasis
|
1R21CA219958-01A1
|
$208,800
|
|
BARELI, MENASHE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Tumor Suppression by an African Specific Variant of p53
|
1F32CA220972-01A1
|
$59,038
|
|
BARNOUD, THIBAUT
|
WISTAR INSTITUTE
|
|
Bioinformatic Analysis of Next Generation Sequencing Data from Cancer Cells
|
5R50CA221848-02
|
$173,980
|
|
BARTOM, ELIZABETH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Molecular and Imaging Assessment of Fallopian Tube Health
|
1R21CA229707-01
|
$188,966
|
|
BARTON, JENNIFER
|
UNIVERSITY OF ARIZONA
|
|
Using hunger training to enhance weight loss and modulate cancer-related biomarkers in women at high risk for breast cancer: a pilot study
|
5R21CA215415-02
|
$174,000
|
|
BASEN-ENGQUIST, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA217685-02
|
$1,813,624
|
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The GNAQ pathway as a therapeutic target in uveal melanoma
|
5R01CA142873-08
|
$306,698
|
$306,698
|
BASTIAN, BORIS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
Total relevant funding to Eye for this search: $8,901,282
|